Ledger.Open graph →
SEC Form D · filed November 5, 2021

CuraSen Therapeutics, Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Carlos, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Anthony P. Ford · San Carlos, CAExec · DirectorRon S. Hunt · San Carlos, CADirectorLoretta S. Tse, Ph.D · San Carlos, CADirectorPatrick S. Enright · San Carlos, CADirectorKathleen S. Glaub · San Carlos, CADirectorBenjamin S. Potter · Menlo Park, CAExecSimon S. Tate · San Carlos, CADirectorThomas Miller · Bonita Springs, FLDirectorBradley Rymer · Bonita Springs, FLDirectorJoseph Hurley · Atlanta, GADirectorEugene Dozortsev · NEW YORK, NYExecBenjamin Singh · Grand Cayman, Cayman IslandsDirectorUjwala Katkade · Dallas, TXExec · DirectorSamuel E. Peck · Dallas, TXDirector(General Partner) Headlands Capital Management, LLC · San Francisco, CAExecBrian Goldberg · Bethlehem, PADirectorErin Lifeso · Bethlehem, PAExec · DirectorSteven T. Faraone · Cleveland, OHDirectorKurt D. Watson · Cleveland, OHDirectorMichael A. Murray · Cleveland, OHDirectorRobert Nistico · FORT LAUDERDALE, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗